vs
P3 Health Partners Inc.（PIII）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
P3 Health Partners Inc.的季度营收约是Rapid7, Inc.的1.8倍（$384.8M vs $217.4M），Rapid7, Inc.净利率更高（1.4% vs -19.6%，领先21.1%），P3 Health Partners Inc.同比增速更快（3.8% vs 0.5%），过去两年Rapid7, Inc.的营收复合增速更高（3.0% vs -0.5%）
P3 Health Partners Inc.是一家总部位于美国的人口健康管理与价值型医疗服务企业，与基层医疗机构及医疗系统合作，为包括联邦医保优势计划参保者在内的人群提供协同优质医疗服务，致力于提升诊疗效果、降低不必要的医疗开支。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
PIII vs RPD — 直观对比
营收规模更大
PIII
是对方的1.8倍
$217.4M
营收增速更快
PIII
高出3.3%
0.5%
净利率更高
RPD
高出21.1%
-19.6%
两年增速更快
RPD
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $384.8M | $217.4M |
| 净利润 | $-75.5M | $3.1M |
| 毛利率 | — | 68.9% |
| 营业利润率 | -40.0% | 1.0% |
| 净利率 | -19.6% | 1.4% |
| 营收同比 | 3.8% | 0.5% |
| 净利润同比 | -28.8% | 44.1% |
| 每股收益（稀释后） | $-23.08 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PIIIRPD
| Q4 25 | $384.8M | $217.4M | ||
| Q3 25 | $345.3M | $218.0M | ||
| Q2 25 | $355.8M | $214.2M | ||
| Q1 25 | $373.2M | $210.3M | ||
| Q4 24 | $370.7M | $216.3M | ||
| Q3 24 | $362.1M | $214.7M | ||
| Q2 24 | $379.2M | $208.0M | ||
| Q1 24 | $388.5M | $205.1M |
净利润PIIIRPD
| Q4 25 | $-75.5M | $3.1M | ||
| Q3 25 | $-31.6M | $9.8M | ||
| Q2 25 | $-20.4M | $8.3M | ||
| Q1 25 | $-20.5M | $2.1M | ||
| Q4 24 | $-58.6M | $2.2M | ||
| Q3 24 | $-46.5M | $15.4M | ||
| Q2 24 | $-12.0M | $6.5M | ||
| Q1 24 | $-18.7M | $1.4M |
毛利率PIIIRPD
| Q4 25 | — | 68.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.6% | ||
| Q1 25 | — | 71.7% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 70.7% | ||
| Q1 24 | — | 70.3% |
营业利润率PIIIRPD
| Q4 25 | -40.0% | 1.0% | ||
| Q3 25 | -12.8% | 2.7% | ||
| Q2 25 | -9.6% | 1.6% | ||
| Q1 25 | -10.2% | -0.0% | ||
| Q4 24 | -37.4% | 3.4% | ||
| Q3 24 | -29.5% | 6.0% | ||
| Q2 24 | -8.3% | 2.5% | ||
| Q1 24 | -11.3% | 4.7% |
净利率PIIIRPD
| Q4 25 | -19.6% | 1.4% | ||
| Q3 25 | -9.1% | 4.5% | ||
| Q2 25 | -5.7% | 3.9% | ||
| Q1 25 | -5.5% | 1.0% | ||
| Q4 24 | -15.8% | 1.0% | ||
| Q3 24 | -12.8% | 7.2% | ||
| Q2 24 | -3.2% | 3.1% | ||
| Q1 24 | -4.8% | 0.7% |
每股收益（稀释后）PIIIRPD
| Q4 25 | $-23.08 | $0.05 | ||
| Q3 25 | $-9.67 | $0.15 | ||
| Q2 25 | $-6.23 | $0.13 | ||
| Q1 25 | $-6.28 | $0.03 | ||
| Q4 24 | $-23.13 | $0.08 | ||
| Q3 24 | $-15.70 | $0.21 | ||
| Q2 24 | $-7.37 | $0.09 | ||
| Q1 24 | $-7.86 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $25.0M | $474.7M |
| 总债务越低越好 | $228.4M | — |
| 股东权益账面价值 | $-155.2M | $154.7M |
| 总资产 | $656.6M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PIIIRPD
| Q4 25 | $25.0M | $474.7M | ||
| Q3 25 | $37.7M | $407.1M | ||
| Q2 25 | $38.6M | $511.7M | ||
| Q1 25 | $40.1M | $493.5M | ||
| Q4 24 | $38.8M | $521.7M | ||
| Q3 24 | $63.0M | $443.7M | ||
| Q2 24 | $73.1M | $442.6M | ||
| Q1 24 | $27.3M | $411.7M |
总债务PIIIRPD
| Q4 25 | $228.4M | — | ||
| Q3 25 | $252.8M | — | ||
| Q2 25 | $182.0M | — | ||
| Q1 25 | $171.1M | — | ||
| Q4 24 | $108.9M | — | ||
| Q3 24 | $133.2M | — | ||
| Q2 24 | $133.1M | — | ||
| Q1 24 | $118.1M | — |
股东权益PIIIRPD
| Q4 25 | $-155.2M | $154.7M | ||
| Q3 25 | $-18.7M | $127.2M | ||
| Q2 25 | $44.5M | $90.4M | ||
| Q1 25 | $63.3M | $52.7M | ||
| Q4 24 | $75.9M | $17.7M | ||
| Q3 24 | $120.5M | $-5.1M | ||
| Q2 24 | $166.8M | $-52.6M | ||
| Q1 24 | $146.6M | $-86.4M |
总资产PIIIRPD
| Q4 25 | $656.6M | $1.7B | ||
| Q3 25 | $683.6M | $1.7B | ||
| Q2 25 | $731.6M | $1.6B | ||
| Q1 25 | $783.9M | $1.6B | ||
| Q4 24 | $783.4M | $1.7B | ||
| Q3 24 | $833.3M | $1.6B | ||
| Q2 24 | $892.8M | $1.5B | ||
| Q1 24 | $855.9M | $1.5B |
负债/权益比PIIIRPD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.09× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.80× | — | ||
| Q1 24 | 0.81× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.7M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.4M |
| 自由现金流率自由现金流/营收 | — | 16.8% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | — | $146.2M |
8季度趋势，按日历期对齐
经营现金流PIIIRPD
| Q4 25 | $-25.7M | $37.6M | ||
| Q3 25 | $-15.4M | $39.0M | ||
| Q2 25 | $-16.6M | $47.5M | ||
| Q1 25 | $-33.5M | $29.8M | ||
| Q4 24 | $-57.2M | $63.8M | ||
| Q3 24 | $-22.6M | $44.0M | ||
| Q2 24 | $-10.2M | $32.9M | ||
| Q1 24 | $-20.0M | $31.1M |
自由现金流PIIIRPD
| Q4 25 | — | $36.4M | ||
| Q3 25 | — | $34.8M | ||
| Q2 25 | — | $46.6M | ||
| Q1 25 | — | $28.4M | ||
| Q4 24 | — | $62.6M | ||
| Q3 24 | — | $42.6M | ||
| Q2 24 | — | $32.6M | ||
| Q1 24 | — | $30.4M |
自由现金流率PIIIRPD
| Q4 25 | — | 16.8% | ||
| Q3 25 | — | 16.0% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 13.5% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 19.9% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 14.8% |
资本支出强度PIIIRPD
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 0.3% |
现金转化率PIIIRPD
| Q4 25 | — | 12.01× | ||
| Q3 25 | — | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
